Posts about
Biologics
Editorial: Designing a CMC Strategy for Accelerated Development of Biotherapeutics
Alcami recently contributed to a special feature in Drug Development and Delivery magazine titled...
Roundtable Discussion: Novel Therapies
Alcami recently contributed to a roundtable discussion in Pharma's Almanac magazine, answering the...
White Paper: Structural Characterization of Biologics Using High-Resolution Mass Spectrometry
Biopharmaceutical products represent up to 20 percent of the total pharmaceutical market and are...
Understanding Biologics: Your Top 7 Questions Answered
The biologics market represents the leading edge of novel therapeutics and is the fastest growing...
ON-DEMAND WEBINAR: Early Phase Development of Biologics
By some estimates, the pre-approval cost of drug development is a staggering $2.5 billion per drug...
ON-DEMAND WEBINAR: Extractables & Leachables
Requirements from regulatory agencies have become increasingly rigorous with regards to the...
Framework to Biologics – Part Two
Part Two: Cell-Based Bioassays
In part one of this biologics series, leading Alcami experts...